Oxoneg Injection contains Glutathione 600 mg per dose, a potent antioxidant utilized in various clinical settings for its detoxifying and cytoprotective properties. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, playing a critical role in cellular defense against oxidative stress by neutralizing free radicals and reactive oxygen species. Oxoneg Injection is indicated for the management of conditions associated with oxidative damage, including liver disorders such as chronic hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease. It is also employed as an adjunct therapy in the treatment of certain neurodegenerative diseases and to enhance skin depigmentation in hyperpigmentation disorders. The injectable formulation ensures rapid bioavailability and effective systemic delivery. Administration should be performed under medical supervision, with dosage tailored according to the clinical condition and patient response. Common adverse effects are generally mild and may include injection site reactions. Caution is advised in patients with known hypersensitivity to glutathione or any component of the formulation. Oxoneg Injection should be stored according to manufacturer guidelines to maintain stability and efficacy. Its use contributes significantly to the restoration of cellular redox balance and supports overall metabolic health.